Inhibition of E-cadherin expression has been described in BRAF-driven thyroid tumors in which the MAPK pathway is activated [41], but little is known about the mechanisms involved in E-cadherin repression in RAS-driven tumors where PI3K/AKT is activated. The gene discussed is BRAF; the disease is thyroid tumor.